A Brazilian study in the Journal of Clinical Pharmacy and Therapeutics found sofosbuvir-based treatment demonstrated a 98.9% rate of sustained virological response among patients with chronic hepatitis C virus and a significant improvement in renal biomarkers among those with mild or moderate renal impairment. The findings were based on data for 94 patients.
Sofosbuvir tied to kidney improvement for some patients
Sign up for ACG SmartBrief
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.